Inconsistent Reconstitution of Cytomegalovirus‐Specific Cell‐Mediated Immunity in Human Immunodeficiency Virus–Infected Patients Receiving Highly Active Antiretroviral Therapy

Abstract
Cytomegalovirus (CMV)–immune recovery was characterized in human immunodeficiency virus (HIV)–infected patients receiving highly active antiretroviral therapy. CMV lymphocyte proliferation (LP), responder-cell frequency (RCF), and interferon (IFN)–γ and interleukin (IL)–2 secretion were studied in CMV-seropositive HIV-infected patients and in CMV-seropositive HIV-uninfected control subjects. HIV-infected patients and control subjects had similar proportions of IL-2 and IFN-γ, but levels were lower in HIV-infected patients. LP and RCF were significantly less frequent and of lower magnitude in HIV-infected patients. The measures of CMV cell–mediated immunity were correlated in HIV-uninfected but not in HIV-infected subjects. To investigate this, IL-2, IL-12, anti-CD28 plus anti-CD49d, or anti–IL-10 was added in vitro, with no effect on LP. However, CD8 cell depletion of mononuclear cells from HIV-infected patients increased LP responses to levels similar to those of uninfected control subjects; before depletion, only RCF correlated with CD4 cell counts, but after depletion, LP also correlated with CD4 cell counts

This publication has 0 references indexed in Scilit: